Silva GD, Castrillo BB, Apostolos-Pereira SL, Callegaro D, et al. Is there a role for off-label high-efficacy disease-modifying drugs in progressive multiple sclerosis? A network meta-analysis. Acta Neurol Scand 2022 Sep 2. doi: 10.1111/ane.13697.
PMID: 36052576